Skip to main content

Global Infectious Disease Diagnostics Market Advances at 7% CAGR Through Policy Support 2030

 


The global infectious disease diagnostics market is set to witness a CAGR of ~7% in the next 5 years. Increasing prevalence of infectious diseases, growing threat of emerging infectious diseases, rise in demand for point-of-care testing, technological advancements, rising awareness and initiatives to control infectious diseases spread, and increasing concerns about antimicrobial resistance, are some of the key factors driving the infectious disease diagnostics market. 

Infectious-disease diagnostics refers to the procedure of detecting, identifying and characterizing the causative agent of an infectious disease. The diagnosis is based on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens and molecular methods among others. The diagnosis involves methods and equipment used to detect infectious agents like bacteria, viruses, fungi, and parasites in human samples. The diagnosis methods can include traditional techniques like culture and microscopy to advanced molecular methods like polymerase chain reaction (PCR), next-generation sequencing (NGS), and rapid point-of-care (POC) tests. Timely diagnostics helps is preventing disease outbreaks, and track the disease course and response to treatment.

Download a free sample report for in-depth market insights
https://meditechinsights.com/infectious-disease-diagnostics-market/request-sample/

Growing threat of emerging infectious diseases to drive market growth

Emerging infectious diseases are either recently appearing or rapidly spreading infections, that can be caused by previously undetected, unknown, newly recognized, or re-emerging infectious agents. WHO has cautioned that the infectious diseases are emerging at a rapid rate, and since past few decades various new infectious diseases have been discovered, like SARS, MERS, Ebola, chikungunya, avian flu, swine flu, Zika and most recently COVID-19. Outbreaks of such infectious diseases can spread rapidly, causing significant losses to health and livelihood. An effective strategy is to prevent or control their spread at an early stage is early detection and identification of disease or disease-causing agents. Rapid and accurate identification of these agents is essential to prevent outbreaks with the correct control measure. The threat of emerging infectious diseases has highlighted the importance of early detection thus fueling the demand for conventional and advanced diagnostics.

Increasing concerns about antimicrobial resistance to boost market growth

Antimicrobial Resistance (AMR) is a phenomenon that occurs when the infectious agents stop responding to antimicrobial medicines. According to WHO, AMR is one of the top global public health and development threats, and the estimated number of deaths attributed to bacterial AMR were 1.27 million in 2019 globally. Over the years microbes have increasingly developed, acquired antimicrobial resistance to many drugs owing to high selection pressure from increasing use and misuse of antibiotics. Widespread overuse and misuse of antibiotics greatly contributes to antibiotic resistance. Diagnostic tests play an important role here as they help determine when and not antibiotics are an appropriate treatment, thus ensuring right treatment is provided at the right time. This is driving the demand for advanced diagnostics that support better antimicrobial stewardship.

Competitive Landscape Analysis

The global infectious disease diagnostics market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd; Abbott; Biomérieux; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; DH Life Sciences, LLC; BD (Becton, Dickinson and Company); Hologic, Inc.; Qiagen; and Revvity; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Unlock key data with a sample report for competitive analysis:
https://meditechinsights.com/infectious-disease-diagnostics-market/request-sample/

Global Infectious Disease Diagnostics Market Segmentation

This report by Medi-Tech Insights provides the size of the global infectious disease diagnostics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product and service, testing type, sample type, technology, disease type, and end user.

Market Size & Forecast (2023-2030), By Product and Service, USD Million

  • Instruments
  • Reagents, Kits and Consumables
  • Software and Services

Market Size & Forecast (2023-2030), By Testing Type, USD Million

  • Laboratory Testing
  • POC Testing

Market Size & Forecast (2023-2030), By Sample Type, USD Million

  • Blood, Serum, and Plasma
  • Urine
  • Others

Market Size & Forecast (2023-2030), By Technology, USD Million

  • Immunodiagnostics
  • Molecular Diagnostics
  • Microbiology
  • Others

Market Size & Forecast (2023-2030), By Disease Type, USD Million

  • Hepatitis
  • Tuberculosis (TB)
  • Sexually Transmitted Infections
  • Hospital-Acquired Infections (HAIs)
  • Influenza
  • Others

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

 About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more